S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7250 +0.29%
CLOSED · 02:40 ET
Market ClerkRecap
Tue Sep 8 · markets closed2 signals on Sep 7189 insider buys this week · $214.6MCIRO short report next: Sep 14The week ahead

AGEN

AGENUS INC
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
8.24
+0.00 +0.00%
USD · close Sep 4

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $371MP/E 3.2DIV YIELD FCF YIELD -26.55%REV TTM $132.7M +30.5%NET INCOME $91.9MNET DEBT $11.3M52W 2.77 – 8.36SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 62 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q2 2026 · Jun 30$34.5M+34.4%100.0%$11.3M−$567K-0.01−$31.2M$0−$31.2MAug 7
Q1 2026 · Mar 31$33.7M+40.2%100.0%$15.1M$39.2M1.02−$36M$0−$36MAug 7
Q4 2025 · Dec 31derived$34.2M+27.5%100.0%$14.4M−$10.6M-0.37−$16.6M$0−$16.6MMar 16
Q3 2025 · Sep 30$30.2M+20.4%97.9%−$4.5M$63.9M1.94−$14.7M$0−$14.7MNov 10
Q2 2025 · Jun 30$25.7M+9.3%99.1%−$16.7M−$30M-1.00−$20.2M$1K−$20.2MAug 7
Q1 2025 · Mar 31$24.1M−14.1%99.4%−$13.3M−$26.4M-1.03−$25.6M$5K−$25.6MAug 7
Q4 2024 · Dec 31derived$26.8M−68.0%99.6%−$25.9M−$46.8M-1.94−$28.7M$73K−$28.7MMar 16
Q3 2024 · Sep 30$25.1M+3.3%99.4%−$31.5M−$67.2M-3.08−$53.3M$7K−$53.3MNov 10
Q2 2024 · Jun 30$23.5M99.5%−$30.2M−$54.8M-2.52−$38.2M$461K−$38.6MNov 10
Q1 2024 · Mar 31$28M99.6%−$32.9M−$63.5M-3.04−$38.2M$35K−$38.2MNov 10
Q4 2023 · Dec 31derived$83.8M99.7%−$4.2M−$48.6M-2.32−$40.4M$223K−$40.6MMar 16
Q3 2023 · Sep 30$24.3M98.8%−$46.3M−$64.5M-3.29−$65.2M$3.5M−$68.7MNov 12

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Dec 31$114.2M99.1%−$20.2M−$3.1M-2.7%0.00−$77.2M$6K−$77.2M
FY2024 · to Dec 31$103.5M99.5%−$120.5M−$232.3M-224.5%-10.59−$158.3M$576K−$158.9M
FY2023 · to Dec 31$156.3M98.0%−$159.5M−$257.4M-164.7%-13.75−$224.2M$10M−$234.2M
FY2022 · to Dec 31$98M89.2%−$179.4M−$230.7M-235.3%-15.64−$175.4M$53.1M−$228.4M
FY2021 · to Dec 31$295.7M98.8%$25.7M−$28.7M-9.7%-0.11$10.1M$33.8M−$23.7M
FY2020 · to Dec 31$88.2M97.3%−$117.2M−$182.9M-207.4%-1.05−$139.1M$3.5M−$142.6M

Every number comes from AGENUS INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch AGEN. Know when insiders buy.
One email the day a filing lands. Free.